Skip to main content
OpenTrials

Clinical trial condition

Attention-Deficit/Hyperactivity Disorder

Explore clinical trials studying Attention-Deficit/Hyperactivity Disorder. Study availability and eligibility vary by location and protocol.

63 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Attention-Deficit/Hyperactivity Disorder trial results

Completed

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00640185

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Site Reference ID/Investigator# 7546 Lafayette, California, United States
  • Site Reference ID/Investigator# 7551 Jacksonville, Florida, United States
  • Site Reference ID/Investigator# 7553 Orlando, Florida, United States
  • Site Reference ID/Investigator# 7545 Overland Park, Kansas, United States
View Trial Details
Completed

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00640419

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Site Reference ID/Investigator# 7536 Little Rock, Arkansas, United States
  • Site Reference ID/Investigator# 7954 Bradenton, Florida, United States
  • Site Reference ID/Investigator# 7543 Jacksonville, Florida, United States
  • Site Reference ID/Investigator# 7542 Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00391729

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Mesa, Arizona, United States
  • Lafayette, California, United States
  • Oceanside, California, United States
  • San Diego, California, United States
View all 23 locations
View Trial Details
Completed

A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00429091

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • Site Reference ID/Investigator# 5965 San Francisco, California, United States
  • Site Reference ID/Investigator# 5955 Wildomar, California, United States
  • Site Reference ID/Investigator# 5974 Orlando, Florida, United States
  • Site Reference ID/Investigator# 5956 West Palm Beach, Florida, United States
View all 22 locations
View Trial Details
Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

NCT00191048

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rolling Hills Estate, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Maitland, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miami, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Libertyville, Illinois, United States
View Trial Details

Related conditions